Limits on costs and values of anticancer drugs in metastatic colorectal cancer: Policies and proposal.

被引：0
|
作者：
Guirgis, Helmy M. [1 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
607
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HOSPITAL COSTS OF ADVERSE EVENTS IN PATIENTS RECEIVING TREATMENT FOR METASTATIC COLORECTAL CANCER
    Fu, A. Z.
    Zhao, Z.
    Wang, S.
    Gao, S.
    Barber, B.
    Liu, G.
    VALUE IN HEALTH, 2011, 14 (03) : A173 - A173
  • [42] Patient-derived Metastatic Colorectal Cancer Mouse Tumorgrafts for Anticancer and Mechanism Studies
    Lemos, R.
    Kopetz, S.
    Jiang, Z.
    Dasari, A.
    Maru, D.
    Powis, G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 20 - 21
  • [43] AUCtox: A new method to evaluate the safety of anticancer drugs in metastatic prostate cancer.
    Launay-Vacher, Vincent
    Helissey, Carole
    Laguerre, Brigitte
    Spaeth, Dominique
    Lloret, Thomas
    Stevens, Jerome
    Bossi, Paolo
    Scotte, Florian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [44] Anticancer drugs and the risk of cardiovascular-related hospitalization in metastatic colorectal cancer: insights from the AVOCETTE registry study in the French county Calvados
    Dolladille, C.
    Launoy, G.
    Bouvier, V.
    Salem, J. E.
    Milliez, P.
    Sassier, M.
    Guittet, L.
    Alexandre, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 116 - 117
  • [45] Scientific summarizing of the results of expert evaluation of anticancer drugs for the treatment of gastric and colorectal cancer
    Nemchenko, A. S.
    Zharkova, S. O.
    Podgaina, M. V.
    Khomenko, V. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2013, (05) : 84 - 87
  • [46] Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
    Rebecca Carter
    Azadeh CheraghchiBashi
    Adam Westhorpe
    Sheng Yu
    Yasmin Shanneik
    Elena Seraia
    Djamila Ouaret
    Yasuhiro Inoue
    Catherine Koch
    Jenny Wilding
    Daniel Ebner
    Anderson JRyan
    Francesca MBuffa
    Ricky ASharma
    Cancer Biology & Medicine, 2019, (02) : 234 - 246
  • [47] Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
    Rebecca Carter
    Azadeh Cheraghchi-Bashi
    Adam Westhorpe
    Sheng Yu
    Yasmin Shanneik
    Elena Seraia
    Djamila Ouaret
    Yasuhiro Inoue
    Catherine Koch
    Jenny Wilding
    Daniel Ebner
    Anderson J.Ryan
    Francesca M.Buffa
    Ricky A.Sharma
    Cancer Biology & Medicine, 2019, 16 (02) : 234 - 246
  • [48] NEW SCREENING SYSTEM FOR SELECTION OF ANTICANCER DRUGS FOR TREATMENT OF HUMAN COLORECTAL-CANCER
    SCHEITHAUER, W
    CLARK, GM
    MOYER, MP
    VONHOFF, DD
    CANCER RESEARCH, 1986, 46 (06) : 2703 - 2708
  • [49] Pharmacokinetics of Anticancer Drugs Used in Treatment of Older Adults With Colorectal Cancer: A Systematic Review
    Shafiei, Mohsen
    Yoon, Robert
    McLachlan, Andrew
    Boddy, Alan
    Beale, Philip
    Blinman, Prunella
    THERAPEUTIC DRUG MONITORING, 2019, 41 (05) : 553 - 560
  • [50] Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer
    Yamaue, H
    Tanimura, H
    Kono, N
    Aoki, Y
    Tabuse, K
    Uchiyama, K
    Takifuji, K
    Iwahashi, M
    Tani, M
    ANTICANCER RESEARCH, 2003, 23 (3B) : 2559 - 2564
12345